Gain Therapeutics
NASDAQ: GANX
$1.71
as on
Gain Therapeutics Stock Performance
as on September 16, 2026 at 2:16 pm IST
Day's Low
Day's High
$1.69$1.74
1.17%
Downside
1.75%
Upside
52 Week's Low
52 Week's High
$1.53$4.3410.53%
Downside
153.80%
Upside
Gain Therapeutics share price movements today
- Previous Close
- $1.74
- Open
- $1.73
- Volume
- 350.9K
- Market Cap
- $76.4M
- Day's Low - High
- $1.69 - $1.74
- 52 Week Low - High
- $1.53 - $4.34
Gain Therapeutics Historical Returns
- 1 Month Return
- -17.92 %
- 3 Month Return
- -0.57 %
- 1 Year Return
- + 6.1 %
- 3 Year Return
- -52.97 %
- 5 Year Return
- -78.17 %
Gain Therapeutics Stock Fundamentals & Key Indicators
Check Gain Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$76.4M
EPS (TTM)
-0.5
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.48
Industry PE ratio
-1.78
PEG Ratio
-0.12094538310412588
EBITDA
-19.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-161.58%
Gain Therapeutics Stock Valuation
Track how Gain Therapeutics P/E has moved over time to understand its valuation trends.
Gain Therapeutics in the last 5 years
Lowest (-5.28x)
December 31, 2025
Today (-5.28x)
December 31, 2025
Industry (-1.78x)
December 31, 2025
Highest (-1.91x)
December 31, 2023
Today’s Price to Earnings Ratio: -5.28x
Gain Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Gain Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $76.4M | -78.17% | -3.48 | 0.00% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $130.6B | 175.08% | 29.76 | 86.04% | NA | |
| BUY | $57.5B | -66.24% | -18.04 | -12.57% | NA | |
| BUY | $80.5B | 21.74% | 18.95 | 84.86% | 47.339999999999996% |
Stock Returns calculator for Gain Therapeutics Stock including INR - Dollar returns
The Gain Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Gain Therapeutics investment value today
Current value as on today
₹1,13,827
Returns
₹13,827
(+13.83%)
Returns from Gain Therapeutics Stock
₹4,268 (+4.27%)
Dollar Impact
₹9,559 (+9.56%)
Analyst Recommendation on Gain Therapeutics Stock
Based on 5 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Gain Therapeutics. Average target price of $7.2
Gain Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Gain Therapeutics.
What analysts predicted
76.25%UPSIDE
Target Price
$7.2
Current Price
$1.71
Analyzed by
5 Analysts
Target
$7.20
Gain Therapeutics target price $7.2, a slight upside of 76.25% compared to current price of $1.71. According to 5 analysts rating.
Indian Investors' Interest in Gain Therapeutics Stock
Search interest for Gain Therapeutics Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Gain Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Gain Therapeutics Annual Profit & Loss
All numbers in Millions USD
Gain Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Gain Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Gain Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 478.8% return, outperforming this stock by 473.9%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 25.5% return, outperforming this stock by 79.3%
NEGATIVE IMPACTPrice Dip
In the last 1 month, GANX stock has moved down by -19.3%
About Gain Therapeutics
| Organisation | Gain Therapeutics |
| Headquarters | 4800 Montgomery Lane, Bethesda, MD, United States, 20814 |
| Industry | Biotechnology |
| CEO | Mr. Gene Mack M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Gain Therapeutics
Name | Title |
|---|---|
Mr. Gene Mack M.B.A. | President, CEO & Director |
Mr. Gianluca Fuggetta | Senior VP of Finance & Principal Financial Officer |
Dr. Terenzio Ignoni Pharm.D. | Chief Operating Officer |
Dr. Joanne Taylor Ph.D. | Chief Scientific Officer |
Dr. Khalid Islam Ph.D. | Chairman & Founder |
FAQs
What is Gain Therapeutics share price today?
Gain Therapeutics share price today is $1.71 as on at the close of the market. Gain Therapeutics share today touched a day high of $1.74 and a low of $1.69.
What is the 52 week high and 52 week low for Gain Therapeutics share?
Gain Therapeutics share touched a 52 week high of $4.34 on and a 52 week low of $1.53 on . Gain Therapeutics stock price today i.e. is closed at $1.71,which is 60.60% down from its 52 week high and 11.76% up from its 52 week low.
What is Gain Therapeutics's market capitalisation today?
Gain Therapeutics market capitalisation is $0.00T as on .
How to invest in Gain Therapeutics Stock (GANX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Gain Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gain Therapeutics Shares that will get you 0.8772 shares as per Gain Therapeutics share price of $1.71 per share as on September 16, 2026 at 8:46 am IST.
What is the minimum amount required to buy Gain Therapeutics Stock (GANX) from India?
Indian investors can start investing in Gain Therapeutics (GANX) shares with as little as ₹95.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.40 in Gain Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Gain Therapeutics share’s latest price of $1.71 as on September 16, 2026 at 8:46 am IST, you will get 5.8480 shares of Gain Therapeutics. Learn more about
fractional shares .
What are the returns that Gain Therapeutics has given to Indian investors in the last 5 years?
Gain Therapeutics stock has given -78.17% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?